Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
96.70    0.75 (0.78%)
Bid:
96.90
Ask:
97.00
Spread: 0.10 (0.103%)
Market Cap: £1.53b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Correction: Scrip Dividend

21 Jun 2022 13:00

RNS Number : 6390P
Sirius Real Estate Limited
21 June 2022
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

21 June 2022

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Correction announcement: Posting of Scrip Dividend Alternative Circular and Scrip Dividend Reference Price and Exchange Rate

Shareholders are referred to the announcement published by the Company on 20 June 2022, advising shareholders, inter alia, of the Scrip Dividend Reference Price and Exchange Rate ("Announcement"). The Company has identified a typographical error in the Announcement, where the number of New Shares which Shareholders who elect to take up the Scrip Dividend Alternative will receive, had been erroneously stated as "2 New Shares" instead of "1 New Share". This typographical error did not impact on the cash dividend value, the Exchange Rate, Scrip Dividend Reference Price or other details disclosed in the Announcement.

Below is an extract of the amended section of the Announcement for ease of reference.

The Scrip Dividend Reference Prices are as follows:

Shareholders on the UK Share Register: £0.97384 (Sterling)

Shareholders on the SA Share Register: 1,921.84233 (ZAR cents)

Therefore, the number of New Shares which Shareholders electing to take the Scrip Dividend Alternative will receive are (subject to the treatment of any fractions) as follows:

Shareholders on the UK Share Register: 1 New Share for every 47.83104 Ordinary Shares held

Shareholders on the SA Share Register: 1 New Share for every 48.39830 Ordinary Shares held

All other details in the Announcement remain unchanged.

For further information:

Sirius Real Estate

Andrew Coombs, CEO

Diarmuid Kelly, CFO

 

 

 

+49 (0)30 285010110

FTI Consulting (financial PR)

Richard Sunderland

Talia Jessener

SiriusRealEstate@fticonsulting.com

 

+44 (0)20 3727 1000

 

 

JSE Sponsor

PSG Capital

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVBFLFLLQLZBBF
Date   Source Headline
30th Jul 20257:00 amRNSNotification of a transaction by a PDMR
25th Jul 202511:00 amRNSDealing in Securities
10th Jul 202511:00 amRNSDirector/PDMR Shareholding
9th Jul 20254:00 pmRNSDirector/PDMR Shareholding
8th Jul 202511:00 amRNSResult of AGM
2nd Jul 202511:00 amRNSNotice of change of AGM venue
30th Jun 20254:15 pmRNSTotal Voting Rights
26th Jun 20257:00 amRNSAcquisition in Geilenkirchen and Disposal of Asset
24th Jun 20257:00 amRNSSirius secures €150m Revolving Credit Facility
11th Jun 20253:00 pmRNSNotifications of transactions by PDMRs
9th Jun 20253:00 pmRNSNotification of a transaction by a PDMR and a PCA
6th Jun 20253:00 pmRNSNotification of a transaction by a PDMR
4th Jun 20254:15 pmRNSPosting of Annual Report and Notice of AGM
3rd Jun 20254:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNS-RSirius appoints Strategic Defence Adviser
2nd Jun 20252:47 pmRNSCash dividend and Dividend Reinvestment Plan
2nd Jun 20257:00 amRNSResults for the year ended 31 March 2025
30th May 20257:00 amRNSSirius agrees €43 million of German transactions
14th May 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSTrading Update
31st Mar 20254:15 pmRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSSirius announces acquisition & disposal of assets
25th Mar 20257:00 amRNSHolding(s) in Company
24th Mar 202512:00 pmRNSChanges to the board committees of the Company
12th Mar 20257:00 amRNSSirius agrees to acquire Southampton Business Park
11th Mar 20257:00 amRNSSirius sells Tyseley business park for £6.7m
17th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20252:00 pmRNSHolding(s) in Company
7th Feb 20253:00 pmRNSResults of Dividend Reinvestment Plan
6th Feb 20258:30 amRNS-RSenior hire strengthens Sirius leadership team
5th Feb 20251:00 pmRNS-RSirius acquires Earl Mill Business Park for £5.7m
4th Feb 20257:00 amRNSSirius to acquire Reinsberg business park
30th Jan 20257:00 amRNSRefinancing at Saarbrücken and MSCI AA ESG rating
29th Jan 20257:00 amRNSDirector/PDMR Shareholding
24th Jan 20257:00 amRNSDirector/PDMR Shareholding
16th Jan 20257:00 amRNSCorporate Bond raising EUR 350 million
19th Dec 202411:00 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSAcquisition
2nd Dec 20242:00 pmRNSDirector update
27th Nov 202411:00 amRNSHolding(s) in Company
20th Nov 202411:30 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSDealing in Securities
18th Nov 20242:00 pmRNSDividend Declaration
18th Nov 20247:00 amRNSHalf-year Report
5th Nov 20247:00 amRNSSirius completes two acquisitions
4th Nov 20247:00 amRNSFitch reaffirms Sirius' BBB credit rating
7th Oct 20247:00 amRNSTrading Update
27th Sep 20243:00 pmRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSHolding(s) in Company
25th Sep 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.